AI Makes Quick Gains in Math, But Errors Still Worry Some Eyeing Reliability
'Big picture, AI is not very good at math,' said Alex Kotran, co-founder and CEO of The AI Education Project. 'Language models just predict the next word. You get mixed results using language models to do math. It's not yet mature enough to where it can be trusted to be scaled.'
And even if it were to improve, critics worry it might hurt kids' ability to try — and fail — on their own. Much would be lost, Kotran said, if 'we get rid of productive struggle and we build this instinct where the first thing you do is go to AI for help.'
Get stories like this delivered straight to your inbox. Sign up for The 74 Newsletter
But students in the United States and the United Kingdom have a different view. A recent survey found 56% believe AI could go a long way in reducing math anxiety.
Fifteen percent of the 1,500 16- to 18-year-old students surveyed said they had already experienced this relief themselves and slightly more than 1 in 5 said their math scores improved because of the technology.
Related
The survey also included 250 teachers. Sixty-one percent suggested students view AI as 'a mentor or study partner rather than a crutch', while nearly half 'see value for students in using AI for help with the process of learning math concepts, rather than to give answers.'
Nicole Paxton, principal of Mountain Vista Community School in Colorado Springs, said her teachers use AI in many ways. Tools like MagicSchoolAI analyze student responses to math prompts, with AI generating 'specific, standards-aligned feedback for each student, focusing on their reasoning, accuracy, and math vocabulary.'
Paxton said the tool highlights strengths and misconceptions, 'which helps teachers give timely and targeted next steps.' The practice saves educators time so they can 'more easily differentiate their re-teaching or follow-up, especially when addressing common errors across the class.'
Robin Lake, director of the Center on Reinventing Public Education, recently looked at the evidence base for using AI in math instruction, including whether it can help the 'shocking number of students' with foundational skills' gaps like those identified in a recent 'Unlocking Algebra' study.
The May 13 analysis by TNTP found that almost half of the students sampled started the class with only one-third of the concepts and skills needed from earlier grades. Lake said AI can be used by schools to identify children who are struggling — and, at least to some degree, by the students themselves.
'AI can be very helpful in analyzing data and identifying gaps in student learning,' she said.
And, if a student wants to learn a mathematical concept in a different way than what they've experienced in class, she said, AI can provide a valuable alternative.
'A lot of students are already doing this,' Lake said.
More districts are training staff to use the technology, though many educators remain reluctant. Terrie Galanti, associate professor at the University of North Florida, said AI success in student learning depends on how teachers are prepared to use it.
'AI can be more than an explainer or an answer giver,' said Galanti, who teaches secondary mathematics and STEM integration/computational thinking. 'With thoughtful prompts, AI can become part of interactive, collaborative conversations to deepen mathematics understanding.'
The National Council of Teachers of Mathematics said in a February 2024 position paper that teachers have long been accustomed to technological advances that change the way students learn.
Related
They had already adjusted to the availability of pocket calculators in the early '80s and, more recently, to the widespread use of PhotoMath, a mobile app that recognizes and solves math problems.
It notes that advancements in AI make teachers more, not less valuable, in student learning.
Latrenda Knighten, the organization's president, told Education Week in March that students will still need to rely upon their own discernment to solve mathematical problems — regardless of what tools become available.
'We know that children learn math from being able to problem-solve, being able to use reasoning skills, critical thinking, having opportunities to collaborate with each other and talk about what they're doing,' Knighten said.
Irina Lyublinskaya, professor in the department of mathematics, science, and technology at Teachers College, Columbia University, distinguished between chatbots like ChatGPT and computational knowledge engines like WolframAlpha. She noted math specific AI-powered applications — including WolframAlpha and Symbolab — work very well.
'AI chatbots can help students learn math, and they can help teachers to support students, but this is not about asking ChatGPT to solve a math problem,' she said. 'I know of research-based initiatives that use AI to adapt learning materials to students' learning styles and abilities and these definitely help students learn.'
One, she noted, was EvidenceB, developed by researchers and educators in Europe, and is now being tested in NYC.
Related
'Chatbots can be trained as teaching assistants or tutors that can provide students proper scaffolding and feedback, helping them to learn math the same way they would with a real person,' she said.
Zachary A. Pardos is an associate professor of education at the University of California Berkeley where he studies adaptive learning and AI. He found, in a study conducted a year ago, that 25% of the answers provided by ChatGPT in algebra were incorrect.
'That's pretty high,' he noted. 'Much higher than you would want.'
But the technology has improved since then.
'With the right techniques — at least in algebra — from an error perspective, I feel it is ready for real-time intervention in math,' he said.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
6 hours ago
- Yahoo
Versailles Hospital Center adopts digital pathology platform
The Versailles Hospital Center has begun a digital pathology transformation by selecting Tribun Health's CaloPix imaging platform. This move is a significant step in modernising the French public healthcare system's diagnostic services and integrating artificial intelligence (AI) into pathology. The implementation of CaloPix within the pathology department is set to streamline primary diagnostics and interdisciplinary collaboration. Tribun Health CEO Jean-François POMEROL said: 'This choice reflects a shared commitment to innovating for more effective, collaborative, and patient-centered healthcare.' Tribun Health's platform has a user-friendly interface and flexibility, catering to the dynamic requirements of hospital infrastructures. It is designed to be open and interoperable, allowing it to integrate with the hospital's digital strategy. This initiative is in line with the Versailles Hospital Center and GHT 78 Sud's digital objectives, which are coordinated with GHT Nord. It contributes to a national effort to upgrade and digitise healthcare facilities. Versailles Hospital Center is GHT 78 Sud's supporting institution. Versailles Hospital Center Pathology Department head Dr Claire GLASER said: 'The selection of CaloPix is fully aligned with our digital transformation strategy. We were impressed by the solution's user-friendliness, performance, and the quality of support offered by Tribun Health's teams. 'This project, developed in collaboration with the GHT Yvelines Nord, marks a key step for the future of our specialty in the region, particularly regarding AI and collaborative work. It also enhances our integration into APHP's expert networks equipped with the same software.' Tribun Health uses data-driven technology and AI to improve precision and minimise turnaround times to assist laboratories and hospitals in transitioning from glass slide pathology to complete digital solutions. "Versailles Hospital Center adopts digital pathology platform" was originally created and published by Hospital Management, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Yahoo
6 hours ago
- Yahoo
Medimaps launches AI-image software for osteoporosis in Europe
Switzerland-based Medimaps has launched a new version of its artificial intelligence (AI)-based image processing software for osteoporosis assessment in Europe. Trabecular Bone Score (TBS) Osteo Advanced uses AI to correct for soft tissue thickness anterior to the lumbar spine to ensure greater TBS assessment accuracy across a wide range of body types. This latest software builds on the original TBS Osteo, which was first introduced in 2012. The new version can be centrally managed through healthcare organisations' Dual-energy X-ray (DXA) scanners for bone density assessment, with workflows standardised across multiple locations. TBS Osteo Advanced is available under a subscription model, allowing healthcare organisations to keep up to date with the latest developments in osteoporosis care. The European launch follows its certification under the EU's Medical Device Regulation (EU MDR) in January 2025. The software received 510(k) clearance from the US Food and Drug Administration (FDA) in the same month and launched across the US in June. According to Medimaps, since the US launch in 2012, TBS Osteo has been adopted by 16 of the country's top 20 hospitals and healthcare providers. Medimaps CEO Dr Didier Hans said the updated version of TBS Osteo has been developed to provide radiologists with a maximum of clinical output with a minimum of logistics. 'Designed for seamless integration into clinical workflows, it requires no additional exam time or extra appointments – an essential advantage for busy radiology professionals,' Hans said. 'TBS Osteo delivers within seconds a comprehensive report combining bone mineral density (BMD) and clinical factors, providing results beyond the standard of care.' Medimaps' TBS Osteo Advanced is built on its TBS iNsight engine which received EU MDR certification in 2023. Osteoporosis weakens bones and increases the risk of bone fractures. According to the International Osteoporosis Foundation, around 32 million Europeans aged 50 and above live with the condition. Across the EU, Switzerland, and the UK, osteoporotic fractures are projected to rise to 5.3 million annually by 2034, up from 4.9 million in 2019. Research by the United Nations (UN) projects that the global population aged 60 and above will reach around 2.1 billion by 2050. According to GlobalData analysis, the ageing population is set to have a profound influence on the medical device industry, with early detection and diagnosis of age-related diseases viewed as a critical determinate in improving health outcomes. "Medimaps launches AI-image software for osteoporosis in Europe" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio
Yahoo
6 hours ago
- Yahoo
Modella AI and AstraZeneca link for cancer clinical development
Modella AI has signed a multi-year agreement with AstraZeneca to expedite AI-driven oncology clinical development. The partnership will give AstraZeneca access to Modella AI's multi-modal foundation models. The agreement will enable the use of Modella AI's latest models, with rich feature extraction from different types of data, to speed up clinical development across AstraZeneca's worldwide oncology portfolio. AstraZeneca oncology research and development (R&D) chief AI and data scientist Jorge Reis-Filho stated: 'At AstraZeneca, AI is integrated across every aspect of clinical development. 'Through the use of foundation models, combined with our unique datasets and AI expertise, we are confident in our strategy to accelerate development and increase the probabilities of success in our oncology clinical trials.' AstraZeneca will use Modella AI's platform for cancer research R&D capabilities to improve biomarker discovery and clinical development while enhancing patient outcomes. By integrating these advanced foundation models into its R&D pipeline, AstraZeneca seeks to enable data-driven discovery methods with increased speed. Modella AI CEO Jill Stefanelli stated: 'Foundation models are transforming precision medicine. They are the backbone of AI-powered biomedical discovery and mark the first step toward fully autonomous AI agents. 'Our state-of-the-art multimodal foundation models provide powerful features from different data types for downstream tasks. When integrated with AstraZeneca's research engine, they will have the potential to accelerate data-driven development and enable the development of new AI agents that can automate complex R&D workflows.' In June 2025, the US Food and Drug Administration (FDA) approved AstraZeneca and Daiichi Sankyo's Datroway (datopotamab deruxtecan) for the treatment of adults with locally advanced or metastatic non-small cell lung cancer (NSCLC) that exhibits mutations in the epidermal growth factor receptor. "Modella AI and AstraZeneca link for cancer clinical development" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data